Skip to main content
OpenTrials

Clinical trial condition

Pathologic Processes

Explore clinical trials studying Pathologic Processes. Study availability and eligibility vary by location and protocol.

54,940 public trials 8,591 recruiting studies
Refine in advanced search Browse all conditions

Pathologic Processes trial results

Recruiting

Fibrosis Lessens After Metabolic Surgery

NCT06374875

Conditions
Body Weight, Digestive System Diseases, Fatty Liver, +16 more
Locations
  • Banner Health Center Phoenix, Arizona, United States
  • Indiana University Indianapolis, Indiana, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View all 22 locations
View Trial Details
Recruiting

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

NCT07298473

Conditions
Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +6 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
  • Scripps Green Hospital La Jolla, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • NCH Rooney Heart Institute Naples, Florida, United States
View all 30 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT07306832

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Lucile Packard Children's Hospital /ID# 276015 Palo Alto, California, United States
  • New York Medical College /ID# 275597 Valhalla, New York, United States
  • Tristar Centennial Medical Center /ID# 275831 Nashville, Tennessee, United States
  • Perth Children'S Hospital /ID# 275673 Perth, Western Australia, Australia
View Trial Details
Recruiting

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

NCT07342478

Conditions
CLL, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, +23 more
Locations
  • The Center for Cancer and Blood Disorders-Bethesda Bethesda, Maryland, United States
  • Optum Medical Group (Rhodes) P.C. Las Vegas, Nevada, United States
  • OSU Comprehensive Cancer Center Columbus, Ohio, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions